KemPharm
KMPH
$5.81
Share price
-0.34%
Change (1 day)
6.61%
Change (1 year)
Categories
KemPharm (KMPH) - Cash on Hand
Cash on Hand as of December 2022 : $82.84 M
According to KemPharm's latest financial reports the company has $82.84 M in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
KemPharm - Cash on Hand chart (from 2014 to 2022)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2022-12-31 | $82.84 M | -26.26% |
| 2021-12-31 | $0.11 B | 2566.65% |
| 2020-12-31 | $4.21 M | 30.96% |
| 2019-12-31 | $3.21 M | -85.15% |
| 2018-12-31 | $21.66 M | -48.69% |
| 2017-12-31 | $42.22 M | -37.68% |
| 2016-12-31 | $67.76 M | 32.04% |
| 2015-12-31 | $51.32 M | 400.44% |
| 2014-12-31 | $10.25 M | 420.92% |
| 2013-12-31 | $1.96 M |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 Theravance Biopharma
TBPH | $0.10 B | 23.63% | Cayman Islands |
 Jazz Pharmaceuticals JAZZ | $1.81 B | 2,094.88% | 🇮🇪 Ireland |
 ANI Pharmaceuticals ANIP | $0.22 B | 166.90% | 🇺🇸 USA |
 Agile Therapeutics
AGRX | $2.55 M | -96.91% | 🇺🇸 USA |